Jagsonpal Pharmaceuticals Limited has entered into a Business Transfer Agreement (BTA) with Group Pharmaceuticals Limited to acquire its Wellness Portfolio, in a transaction that could have a total consideration of up to ₹46.7 crore.
According to the company’s regulatory disclosure dated September 23, 2026, the acquisition will be undertaken on a going-concern basis through a slump sale. Jagsonpal said the move is aimed at strengthening its pharmaceutical portfolio, expanding its presence across relevant therapeutic segments and increasing its market reach.
Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) announced results from a new analysis showing that Foundayo (orforglipron) 17.2 mg was associated with significantly greater weight loss and better blood sugar control than oral semaglutide 25 mg in adults with type 2 diabetes.
In observance of the 6th National Pharmacovigilance Week 2026, the Department of Pharmacy Practice, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, in collaboration with the Indian Pharmaceutical Association – Hospital Pharmacy Division (IPA-HPD), organized a series of awareness and educational programmes from September 17 to 23, 2026.
The Drugs Technical Advisory Board, DTAB, has recommended changes to the regulatory requirements for manufacturing drugs intended for clinical trials, bioavailability and bioequivalence studies, analytical testing and non-clinical studies.
The competition between Novo Nordisk and Eli Lilly in the diabetes and obesity medicine market is producing a new wave of comparative clinical data. In September 2026, both companies released analyses comparing their medicines with competing therapies, but the results are not all pointing in the same direction.
The United States has issued new guidance explaining how certain specialty pharmaceutical products and associated pharmaceutical ingredients can qualify for a zero percent tariff under the countrys latest pharmaceutical import tariff framework.
Development and Clinical Validation of a Point-of-Need Therapeutic Drug Monitoring–Guided Precision Dosing Platform for Polymyxin B in Critically Ill Patients with Renal Impairment. Manipal Academy of Higher Education
M.S (Pharm) / M. Pharm in Pharmacology /Pharmacology and Toxicology or equivalent with minimum of 60% marks or 6.5/10 CGPA. GPAT/NET/GATE qualified candidate will be preferred Candidates with experience in behavioural animal studies and knowledge of cell and molecular biology will be preferred. NIPER Kolkata
The Indian Institute of Technology Jammu was inaugurated on 6th August 2016, and welcomed the first batch of students into the campus in Paloura, Jammu. In the initial phases, the establishment of IIT Jammu was done under the mentorship of IIT Delhi. In 2018, IIT Jammu shifted its primary operations to the 400 acres of lush green land in Jagti village, just outside Jammu city, provided by the Government of Jammu and Kashmir for establishing its main campus.
M.Sc., B.E., B.Tech., B.V.Sc., B.Pharm., or equivalent degree and at least two years of post-M.Sc., B.E., B.Tech., B.V.Sc., B.Pharm. research experience, as evidenced from published papers in standard refereed journals. Bharathidasan University, Tiruchirappalli
M.Sc. / M.Tech. / B.Tech./ M.Pharm / MS in: Biochemistry/ Biotechnology/ Microbiology/ Molecular Biology or any other relevant branch of Modern Biology.
MSc./ Integrated M.Sc in any branch of Science (e.g. Biology, Chemistry, Physics), MTech., MPharm, M.B.B.S., four-year Bachelors degree or equivalent qualification as per the norms of RCB and from a recognised University or institution.
Graduate degree in Life Sciences or an allied basic-science discipline relevant to biomedical research from a recognized university or institution. ICMR
M.Pharm (Pharmaceutics or related specialization) with experience in formulation development and evaluations. OR PhD in Pharmaceutical Sciences or related area. Manipal Academy of Higher Education
M.Pharm, MSc; Ability to perform daily instrument calibration and verification of routine calibration records performed by external party. Torrent Pharma, Executive - Bioanalytical
As the Experienced professional in the Medical Affairs Sub-Function, possesses well developed skills in overseeing the direction, planning, execution, clinical trials/research and the data collection activities.